Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: Distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome

Arthritis Care and Research

Volumn 53, Issue 6, 2005, Pages 982-985

  Dold, Sylvia ^a   Singh, Ranju ^a   Sarwar, Haroon ^a   Menon, Yamini ^a   Candia, Liliana ^b   Espinoza, Luis R ^b,c  

^a Ochsner Foundation Hospital   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC; SEVERITY OF ILLNESS INDEX;

EID: 29144522293     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21583     Document Type: Article

References (17)

1. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198-204.
2. Moschowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. New York Pathol Soc 1924;24:21-4.
3. Brain MC, Dacie JV, Hourihane DO. Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol 1962;8:358-74.
4. Ohashi N, Yamamoto T, Kanno D, Fujigaki Y, Yonemura K, Hishida A. A case of thrombotic microangiopathy complicated with systemic lupus erythematosus. Am J Med Sci 2003;326:102-4.
5. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:165-72.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 1999;42:2346-55.
8. Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:1-19.
9. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine (Baltimore) 1981;60:413-28.
10. Fisher DE, Reeves WH, Wisniewolski R, Lahita RG, Chiorazzi N. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 1985;28:1348-55.
11. Gedalia A, Molina JF, Molina J, Uribe O, Malagon C, Espinoza LR. Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans, J Natl Med Assoc 1999;91:497-501.
12. Molina JF, Molina J, Garcia C, Gharavi AE, Wilson WA, Espinoza LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 1997;6:63-7.
13. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992;20:150-8.
14. Cucurull E, Espinoza LR, Mendez E, Molina JF, Molina J, Ordi-Ros J, et al. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards. Lupus 1999;8:134-41.
15. Cucurull E, Gharavi AE, Diri E, Mendez E, Kapoor D, Espinoza LR. IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999;318:55-60.
16. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al, and the Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
17. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, and the Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Eng J Med 1992;326:1373-9.